# Aliskiren Fumarate Tablets 150mg (ラジレス錠１５０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2149047F1028). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2149047F1028
- **Product name (Japanese):** ラジレス錠１５０ｍｇ
- **English title:** Aliskiren Fumarate Tablets 150mg
- **Active ingredient:** アリスキレンフマル酸塩
- **Active ingredient (INN):** Aliskiren Fumarate
- **Strength / unit:** １５０ｍｇ１錠
- **Route:** Oral (内用薬)
- **Therapeutic category:** 21 Cardiovascular agents (循環器官用薬) › 214 Antihypertensives (血圧降下剤)
- **Manufacturer:** Orphan Pacific (オーファンパシフィック)
- **NHI price (reference only):** JPY 83.5 per １５０ｍｇ１錠
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2149047F1028
- **JSON:** https://www.nifujipharma.com/api/drugs/2149047F1028

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Aliskiren%20Fumarate%20Tablets%20150mg%20(%E3%83%A9%E3%82%B8%E3%83%AC%E3%82%B9%E9%8C%A0%EF%BC%91%EF%BC%95%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%202149047F1028#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.
